Combination of EGb 761 & Acetylcholinesterase Inhibitors Reduces Cognitive Impairment and Neuropsychiatric Symptoms in Subjects with Mild Cognitive Impairment
Written by Taylor Woosley, Science Writer. 12-month supplementation of EGb 761 either alone or in combination with AChEI was associated with improved cognitive abilities and reduced neuropsychiatric symptoms.





